SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-21-088820
Filing Date
2021-07-02
Accepted
2021-07-02 15:49:54
Documents
4
Group Members
ALLEN GABRIELANTHONY CARACCIOLOANTONIO PARISIARLYN J. BOSSENBROOKARTHUR L. WILMESBRANDON THORSONBRUCE K. PATTERSON, M.D.CHARLES M. JOHNSON JR.FRANCESCO TOSCOFREDERICK AXELBERDGLENN EISENBERGJACK CHITAYATJEFFREY P. BEATYJEFFREY WEINERJOE RECTORJONATHAN HAR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2121222d2_sc13da.htm SC 13D/A 405815
2 EXHIBIT 99.11 tm2121222d2_ex99-11.htm EX-99.11 10311
3 EXHIBIT 99.12 tm2121222d2_ex99-12.htm EX-99.12 24431
4 EXHIBIT 99.13 tm2121222d2_ex99-13.htm EX-99.13 8116
  Complete submission text file 0001104659-21-088820.txt   450974
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Subject) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: SC 13D/A | Act: 34 | File No.: 005-79349 | Film No.: 211069762
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2945 NW LURAY TERRACE PORTLAND OR 97210
Business Address
Rosenbaum Paul (Filed by) CIK: 0001863643 (see all company filings)

Type: SC 13D/A